HCA Healthcare stock price target raised to $541 from $503 at Bernstein

NodeGuardian · 2026-02-22T00:07:52+00:00

Bernstein SocGen Group raised HCA Healthcare's price target to $541 due to improved margins and strong buyback potential, while maintaining a Market Perform rating amid valuation concerns and slowing growth.

NodeGuardian

2026-02-22 00:07:52

Abstract generation in progress

Bernstein SocGen Group has increased its price target for HCA Healthcare Inc (NYSE:HCA) to $541 from $503, while maintaining a Market Perform rating. This adjustment reflects HCA’s improved margin efficiency and robust share buyback capacity, with Bernstein raising EBITDA forecasts by 2-3% for the next five years. Despite the positive outlook on financial performance, concerns about high valuations and moderating rate growth led to the continued Market Perform rating.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.